Distinct patterns of angiogenesis in oral and skin wounds

Journal of Dental Research

Volumn 84, Issue 4, 2005, Pages 309-314

  Szpaderska, A M ^a   Walsh, C G ^a   Steinberg, M J ^a   DiPietro, L A ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Oral mucosa; Skin; VEGF; Wound healing

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; FEMALE; HUMAN; INJURY; KERATINOCYTE; METABOLISM; MOUSE; MOUTH MUCOSA; SKIN; VASCULARIZATION;

ANIMALS; CELLS, CULTURED; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; KERATINOCYTES; MICE; MICE, INBRED BALB C; MOUTH MUCOSA; NEOVASCULARIZATION, PHYSIOLOGIC; RNA, MESSENGER; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 27744529921     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910508400403     Document Type: Article

References (22)

1. Ballaun C, Weninger W, Uthman A, Weich H, Tschachler E (1995). Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 104:7-10.
2. Berger AC, Feldman AL, Gnant MF, Kruger EA, Sim BK, Hewitt S, et al. (2000). The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing. J Surg Res 91:26-31.
3. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR (1992). Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3:211-220.
4. Bloch W, Huggel K, Sasaki T, Grose R, Bugnon P, Addicks K, et al. (2000). The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing. FASEB J 14:2373-2376.
5. Brakenhielm E, Cao R, Cao Y (2001). Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 15:1798-1800.
6. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, et al. (1992). Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176:1375-1379.
7. Detmar M, Yeo KT, Nagy JA, Van de Water L, Brown LF, Berse B, et al. (1995). Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 105:44-50.
8. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S (1995). Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270:12607-12613.
9. Kishimoto J, Ehama R, Ge Y, Kobayashi T, Nishiyama T, Detmar M, et al. (2000). In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin. Am J Pathol 157:103-110.
10. Klein SA, Bond SJ, Gupta SC, Yacoub OA, Anderson GL (1999). Angiogenesis inhibitor TNP-470 inhibits murine cutaneous wound healing. J Surg Res 82:268-274.
11. Knighton DR, Silver IA, Hunt TK (1981). Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 90:262-270.
12. Mundhenke C, Thomas JP, Wilding G, Lee FT, Kelzc F, Chappell R, et al. (2001). Tissue examination to monitor antiangiogenic therapy: a phase I clinical trial with endostatin. Clin Cancer Res 7:3366-3374.
13. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA (1998). Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152:1445-1452.
14. Oda D, Watson E (1990). Human oral epithelial cell culture I. Improved conditions for reproducible culture in serum-free medium. In Vitro Cell Dev Biol 26:589-595.
15. Pammer J, Weninger W, Mildner M, Burian M, Wojta J, Tschachler E (1998). Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals. J Pathol 186:186-191.
16. Roman CD, Choy H, Nanney L, Riordan C, Parman K, Johnson D, et al. (2002). Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats. J Surg Res 105:43-47.
17. Swift ME, Kleinman HK, DiPietro LA (1999). Impaired wound repair and delayed angiogenesis in aged mice. Lab Invest 79:1479-1487.
18. Szpaderska AM, Zuckerman JD, DiPietro LA (2003). Differential injury responses in oral mucosal and cutaneous wounds. J Dent Res 82:621-626.
19. Taichman NS, Cruchley AT, Fletcher LM, Hagi-Pavli EP, Paleolog EM, Abrams WR, et al. (1998). Vascular endothelial growth factor in normal human salivary glands and saliva: a possible role in the maintenance of mucosal homeostasis. Lab Invest 78:869-875.
20. Tanaka H, Taniguchi H, Mugitani T, Koishi Y, Masuyama M, Koyama H, et al. (1996). Angiogenesis inhibitor TNP-470 prevents implanted liver métastases after partial hepatectomy in an experimental model without impairing wound healing. Br J Surg 83:1444-1447.
21. te Velde EA, Kusters B, Maass C, de Waal R, Borel Rinkes IH (2003). Histological analysis of defective colonie healing as a result of angiostatin treatment. Exp Mol Pathol 75:119-123.
22. Viac J, Palacio S, Schmitt D, Claudy A (1997). Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes. Arch Dermatol Res 289:158-163.